Study investigated epcoritamab combined with rituximab and lenalidomide for treatment of relapsed follicular lymphoma.
Home / Resource Library / Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma